Fresenius Loses 'Unduly Speculative' Generic Drug Row

A New Jersey federal judge on Tuesday tossed Fresenius Kabi's antitrust suit against Par Pharmaceuticals, which alleged that the drug ingredient maker blocked it from marketing a generic version of an...

Already a subscriber? Click here to view full article